Search by Drug Name or NDC
NDC 68047-0721-01 Butalbital And Acetaminophen 325; 50 mg/1; mg/1 Details
Butalbital And Acetaminophen 325; 50 mg/1; mg/1
Butalbital And Acetaminophen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL.
Product Information
| NDC | 68047-0721 |
|---|---|
| Product ID | 68047-721_0771bcff-6b38-c003-e063-6294a90a32a8 |
| Associated GPIs | 64991002120310 |
| GCN Sequence Number | 004459 |
| GCN Sequence Number Description | butalbital/acetaminophen TABLET 50MG-325MG ORAL |
| HIC3 | H3K |
| HIC3 Description | ANALGESIC, NON-SALICYLATE AND BARBITURATE COMBINAT |
| GCN | 72711 |
| HICL Sequence Number | 001858 |
| HICL Sequence Number Description | BUTALBITAL/ACETAMINOPHEN |
| Brand/Generic | Generic |
| Proprietary Name | Butalbital And Acetaminophen |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | butalbital and acetaminophen |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 325; 50 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; BUTALBITAL |
| Labeler Name | Larken Laboratories, Inc. |
| Pharmaceutical Class | Barbiturate [EPC], Barbiturates [CS] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA203484 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68047-0721-01 (68047072101)
| NDC Package Code | 68047-721-01 |
|---|---|
| Billing NDC | 68047072101 |
| Package | 100 TABLET in 1 BOTTLE (68047-721-01) |
| Marketing Start Date | 2015-12-04 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.12642 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis